Transcatheter aortic valve implantation: Patient selection

Minerva Cardioangiologica

Volumn 61, Issue 5, 2013, Pages 487-497

  Stortecky, S ^a   O'Sullivan, C J ^a   Buellesfeld, L ^a   Wenaweser, P ^a   Windecker, S ^a  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Aortic valve stenosis; Heart valve prosthesis implantation; Patient selection

Indexed keywords

ALGORITHM; AORTA ROOT; AORTA STENOSIS; AORTA VALVE REPLACEMENT; HIGH RISK PATIENT; HUMAN; PATIENT REFERRAL; PATIENT SELECTION; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT INDICATION;

AGED; ALGORITHMS; AORTIC VALVE; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PATIENT CARE TEAM; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

EID: 84890543031     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: First human case description. Circulation 2002;106:3006-8. (Pubitemid 35440280)
2. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-607.
3. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364:2187-98.
4. Dvir D, Webb J, Brecker S, Bleiziffer S, Hildick-Smith D, Colombo A et al. Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: Results from the global valve-in-valve registry. Circulation 2012;126:2335-44.
5. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Bar-on-Esquivias G, Baumgartner H et al. Guidelines on the management of valvular heart disease (version 2012): The joint task force on the management of valvular heart disease of the european society of cardiology (esc) and the european association for cardio-thoracic surgery (eacts). Eur J Cardiothorac Surg 2012;42:S1-44.
6. Ray-Coquard I, Thiesse P, Ranchere-Vince D, Chauvin F, Bobin JY, Sunyach MP et al. Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomas. Ann Oncol 2004;15:307-15. (Pubitemid 38262633)
7. Tommaso CL, Bolman RM, 3rd, Feldman T, Bavaria J, Acker MA, Aldea G et al. Multisociety (aats, accf, scai, and sts) expert consensus statement: Operator and institutional requirements for transcatheter valve repair and replacement, part 1: Transcatheter aortic valve replacement. J Am Coll Cardiol 2012;59:2028-42.
8. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (euroscore). Eur J Cardiothorac Surg 1999;16:9-13. (Pubitemid 29336425)
9. O'Brien SM, Shahian DM, Filardo G, Ferraris VA, Haan CK, Rich JB et al. The society of thoracic surgeons 2008 cardiac surgery risk models: Part 2-isolated valve surgery. Ann Thorac Surg 2009;88:S23-42.
10. Vahanian A, Alfieri O, Al-Attar N, Antunes M, Bax J, Cormier B et al. Transcatheter valve implantation for patients with aortic stenosis: A position statement from the european association of cardio-thoracic surgery (eacts) and the european society of cardiology (esc), in collaboration with the european association of percutaneous cardiovascular interventions (eapci). EuroIntervention 2008;4:193-9.
11. Piazza N, Wenaweser P, van Gameren M, Pilgrim T, Tzikas A, Otten A et al. Relationship between the logistic euroscore and the society of thoracic surgeons predicted risk of mortality score in patients implanted with the corevalve revalving system - a bern-rotterdam study. Am Heart J 2010;159:323-9.
12. Ben-Dor I, Gaglia MA, Jr., Barbash IM, Maluenda G, Hauville C, Gonzalez MA et al. Comparison between society of thoracic surgeons score and logistic euroscore for predicting mortality in patients referred for transcatheter aortic valve implantation. Cardiovasc Revasc Med 2011;12:345-9.
13. Dewey TM, Brown D, Ryan WH, Herbert MA, Prince SL, Mack MJ. Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg 2008;135:180-7.
14. Nashef SA, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR, Lockowandt U. Euroscore ii. Eur J Cardiothorac Surg 2012;41:734-44; discussion 744-735
15. Watanabe Y, Hayashida K, Lefevre T, Chevalier B, Hovasse T, Romano M et al. Is euroscore ii better than euroscore in predicting mortality after transcatheter aortic valve implantation? Catheter Cardiovasc Interv 2013,81:1053-60.
16. Durand E, Borz B, Godin M, Tron C, Litzler PY, Bessou JP et al. Performance analysis of euroscore ii compared to the original logistic euroscore and sts scores for predicting 30-day mortality after transcatheter aortic valve replacement. Am J Cardiol 2013;111:891-7.
17. Green P, Woglom AE, Genereux P, Daneault B, Paradis JM, Schnell S et al. The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: A single-center experience. JACC Cardiovasc Interv 2012;5:974-81.
18. Stortecky S, Schoenenberger AW, Moser A, Kalesan B, Juni P, Carrel T et al. Evaluation of multidimensional geriatric assessment as a predictor of mortality and cardiovascular events after transcatheter aortic valve implantation. JACC Cardiovasc Interv 2012;5:489-96.
19. Schoenenberger AW, Stortecky S, Neumann S, Moser A, Juni P, Carrel T et al. Predictors of functional decline in elderly patients undergoing transcatheter aortic valve implantation (tavi). Eur Heart J 2013;34:684-92.
20. van Mieghem NM, Head SJ, van der Boon RM, Piazza N, de Jaegere PP, Carrel T et al. The surtavi model: Proposal for a pragmatic risk stratification for patients with severe aortic stenosis. EuroIntervention 2012;8:258-66.
21. Buellesfeld L, Stortecky S, Kalesan B, Gloekler S, Khattab AA, Nietlispach F et al. Aortic root dimensions among patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. JACC Cardiovasc Interv 2013;6:72-83.
22. Piazza N, de Jaegere P, Schultz C, Becker AE, Serruys PW, Anderson RH. Anatomy of the aortic valvar complex and its implications for transcatheter implantation of the aortic valve. Circ Cardiovasc Interv 2008;1:74-81.
23. Moss RR, Ivens E, Pasupati S, Humphries K, Thompson CR, Munt B et al. Role of echocardiography in percutaneous aortic valve implantation. JACC Cardiovasc Imaging 2008;1:15-24. (Pubitemid 351445392)
24. Smith LA, Dworakowski R, Bhan A, Delithanasis I, Hancock J, Maccarthy PA et al. Real-time three-dimensional transesophageal echocardiography adds value to transcatheter aortic valve implantation. J Am Soc Echocardiogr 2013;26:359-69.
25. Messika-Zeitoun D, Serfaty JM, Brochet E, Ducrocq G, Lepage L, Detaint D et al. Multimodal assessment of the aortic annulus diameter: Implications for transcatheter aortic valve implantation. J Am Coll Cardiol 2010;55:186-94.
26. Schultz CJ, Moelker A, Piazza N, Tzikas A, Otten A, Nuis RJ et al. Three dimensional evaluation of the aortic annulus using multislice computer tomography: Are manufacturer's guidelines for sizing for percutaneous aortic valve replacement helpful? Eur Heart J 2010;31:849-56.
27. Schultz C, Moelker A, Tzikas A, Piazza N, de Feyter P, van Geuns RJ et al. The use of msct for the evaluation of the aortic root before transcutaneous aortic valve implantation: The rotterdam approach. EuroIntervention 2010;6:505-11.
28. Delgado V, Ewe SH, Ng AC, van der Kley F, Marsan NA, Schuijf JD et al. Multimodality imaging in transcatheter aortic valve implantation: Key steps to assess procedural feasibility. EuroIntervention 2010;6:643-52.
29. Delgado V, Ng AC, Schuijf JD, van der Kley F, Shanks M, Tops LF et al. Automated assessment of the aortic root dimensions with multidetector row computed tomography. Ann Thorac Surg 2011;91:716-23.
30. de Vaan J, Verstraeten L, de Jaegere P, Schultz C. The 3mensio valves multimodality workstation. EuroIntervention 2012;7:1464-9.
31. Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 2012;366:1705-15.
32. Pilgrim T, Stortecky S, Luterbacher F, Windecker S, Wenaweser P. Transcatheter aortic valve implantation and bleeding: Incidence, predictors and prognosis. J Thromb Thrombolysis 2013;35:456-62.
33. Thomas M, Schymik G, Walther T, Himbert D, Lefevre T, Treede H et al. Thirty-day results of the sapien aortic bioprosthesis european outcome (source) registry: A european registry of transcatheter aortic valve implantation using the edwards sapien valve. Circulation 2010;122:62-9.
34. Rodes-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Feindel CM et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: Acute and late outcomes of the multicenter canadian experience. J Am Coll Cardiol 2010;55:1080-90.
35. Hayashida K, Lefevre T, Chevalier B, Hovasse T, Romano M, Garot P et al. Transfemoral aortic valve implantation new criteria to predict vascular complications. JACC Cardiovasc Interv 2011;4:851-8.
36. Kempfert J, Treede H, Rastan AJ, Schonburg M, Thielmann M, Sorg S et al. Transapical aortic valve implantation using a new self-expandable bioprosthesis (acurate ta): 6-month outcomes. Eur J Cardiothorac Surg 2013;43:52-6; discussion 57
37. Treede H, Mohr FW, Baldus S, Rastan A, Ensminger S, Arnold M et al. Transapical transcatheter aortic valve implantation using the jenavalve system: Acute and 30-day results of the multicentre ce-mark study. Eur J Cardiothorac Surg 2012;41:e131-138.
38. Willson AB, Rodes-Cabau J, Wood DA, Leipsic J, Cheung A, Toggweiler S et al. Transcatheter aortic valve replacement with the st. Jude medical portico valve: First-in-human experience. J Am Coll Cardiol 2012;60:581-6.
39. Moat NE, Ludman P, de Belder MA, Bridgewater B, Cunningham AD, Young CP et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: The u.K. Tavi (united kingdom transcatheter aortic valve implantation) registry. J Am Coll Cardiol 2011;58:2130-8.
40. Wenaweser P, Stortecky S, Schwander S, Heg D, Huber C, Pilgrim T et al. Clinical outcomes of patients with estimated low or intermediate surgical risk undergoing transcatheter aortic valve implantation. Eur Heart J 2013 [Epub ahead of print].
41. Stortecky S, Brinks H, Wenaweser P, Huber C, Pilgrim T, Windecker S et al. Transcatheter aortic valve implantation or surgical aortic valve replacement as redo procedure after prior coronary artery bypass grafting. Ann Thorac Surg 2011;92:1324-30; discussion 1230-1321
42. Webb JG, Wood DA, Ye J, Gurvitch R, Masson JB, Rodes-Cabau J et al. Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves. Circulation 2010;121:1848-57.
43. Mylotte D, Lange R, Martucci G, Piazza N. Transcatheter heart valve implantation for failing surgical bioprostheses: Technical considerations and evidence for valve-in-valve procedures. Heart 2013 [Epub ahead of print].